Clinical Trial Update: Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemoradiation with consolidation iparomlimab in older adults with esophageal cancer (esophageal squamous cell carcinoma) is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• iparomlimab

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING